Giannini, Giulia; Kafka, Mona; Neuwirt, Hannes et al.
Safety and Efficacy of 177 Lu-PSMA Therapy Following 223 Radium Treatment: A Retrospective Multinational Real-World AnalysisCLINICAL GENITOURINARY CANCER. Bd. 23. H. 1. 2025
Wolfrum, Peter; Boehm, Elsa Wilma; Koenig, Simon et al.
Safety and Long-Term Efficacy of Intravitreal rtPA, Bevacizumab and SF<sub>6</sub> Injection in Patients with Submacular Hemorrhage Secondary to Age-Related Macular DegenerationJOURNAL OF CLINICAL MEDICINE. Bd. 14. H. 10. 2025 S. 13
Kaemmerer, Peer W.; Engel, Nadja; Bader, Rainer et al.
Safety and preliminary efficacy of an electrically stimulated implant for mandibular bone regeneration: a pilot study in a large animal modelCLINICAL ORAL INVESTIGATIONS. Bd. 29. H. 5. 2025
Schmitt, Volker H.; Hobohm, Lukas; Brochhausen, Christoph et al.
Sarcopenia Influences Clinical Outcome in Hospitalized Patients with Peripheral Artery Disease Aged 75 Years and OlderANNALS OF VASCULAR SURGERY. Bd. 110. 2025 S. 54-65
Ferrea, Stefano; Kuzo, Nazar; Giupponi, Giancarlo et al.
SARS-CoV-2 vaccination and plasma levels of psychotropic agents: a prospective cohort studyEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. Bd. 21. H. 10. 2025 S. 1213-1218
Gaschik, Tara; Ebbach, Claudia; Fischer, Dirk et al.
Scalable multi-layer collagen laminates for regenerative medicineBIOMATERIALS ADVANCES. Bd. 177. 2025
Doenmez, Mustafa Borga; Cakmak, Guelce; Schimmel, Martin et al.
Scan accuracy of recently introduced wireless intraoral scanners in different fixed partial denture situationsJOURNAL OF DENTISTRY. Bd. 153. 2025
Schloesser, Lukas; Ziemssen, Focke; Schuster, Alexander K. et al.
Screening recommendations for glaucoma, age-related macular degeneration and diabetic eye diseasesOPHTHALMOLOGIE. 2025 S. 5
Bernstein, Jonathan A.; Aygoren-Pursun, Emel; Cancian, Mauro et al.
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SCLINICAL AND TRANSLATIONAL ALLERGY. Bd. 15. H. 11. 2025
Wu, Meng; Fulgenzi, Claudia A. M.; D'Alessio, Antonio et al.
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumabJHEP REPORTS. Bd. 7. H. 2. 2025